Propel Bio Management »

Sagimet Biosciences Inc-a shares owned by Propel Bio Management

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $973k 126k 7.73

More positions owned by Propel Bio Management

Plains Gp Holdings Lp-cl Comm (PAGP)
Achieve Life Sciences Comm (ACHV)
Corcept Therapeutics Comm (CORT)
Phathom Pharmaceuticals I Comm (PHAT)
Delcath Systems Comm (DCTH)
Milestone Pharmaceuticals Comm (MIST)
Compass Pathways Adrs (CMPS)
Kyverna Therapeutics Comm (KYTX)
Artiva Biotherapeutics In Comm (ARTV)
Abeona Therapeutics Comm (ABEO)
Aquestive Therapeutics In Comm (AQST)
Palisade Bio Comm (PALI)
Immunic Comm (IMUX)
Inventiva Sa - Comm (IVA)
Sab Biotherapeutics Comm (SABS)

View all positions for Propel Bio Management

Top funds holding Sagimet Biosciences Inc-a

BlackRock
Balyasny Asset Management
Woodline Partners
Silverarc Capital Management
Vanguard Capital Management
BVF
Caligan Partners
Affinity Asset Advisors
Federated Investors
Dr. Jeffrey R. Jay, M.D.
Saturn V Capital Management
Geode Capital Management
Blue Owl Capital Holdings
Baker Bros. Advisors
Millennium Management

View all funds holding Sagimet Biosciences Inc-a